Quick Answer
Gossamer Bio, Inc. reported Net Income of -$170.37 million for fiscal year 2025.
Gossamer Bio, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$170.37M | -201.4% |
| 2024 | -$56.53M | +68.6% |
| 2023 | -$179.82M | +21.6% |
| 2022 | -$229.38M | +2.0% |
| 2021 | -$234.00M | +3.8% |
| 2020 | -$243.36M | -35.0% |
| 2019 | -$180.31M | -22.7% |
| 2018 | -$146.97M | -2070.6% |
| 2017 | -$6.77M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$48.22M | -56.5% | -26.0% |
| June 30, 2025 | -$38.27M | -177.7% | -4.5% |
| March 31, 2025 | -$36.64M | +12.6% | -18.9% |
| September 30, 2024 | -$30.80M | +23.0% | -162.6% |
| June 30, 2024 | $49.23M | +215.9% | +217.4% |
| March 31, 2024 | -$41.93M | +14.7% | -4.8% |
| September 30, 2023 | -$40.01M | +32.6% | +5.9% |
| June 30, 2023 | -$42.50M | +24.7% | +13.6% |
- Gossamer Bio, Inc. showed a decrease of -201.4% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Gossamer Bio, Inc.’s net income has declined by 2416.2% (from -$6.77 million to -$170.37 million).
- The most recent figure is from Gossamer Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: